Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Mar;21(1):163-169.
doi: 10.1007/s42000-021-00330-1. Epub 2021 Oct 25.

Childhood-onset mild diabetes caused by a homozygous novel variant in the glucokinase gene

Affiliations
Review

Childhood-onset mild diabetes caused by a homozygous novel variant in the glucokinase gene

Berna Eroğlu Filibeli et al. Hormones (Athens). 2022 Mar.

Abstract

Purpose: Heterozygous loss-of-function mutations in the glucokinase (GCK) gene cause MODY 2, which is characterized by asymptomatic fasting hyperglycemia and does not require insulin treatment. Conversely, homozygous loss-of-function mutations in the same gene give rise to permanent neonatal diabetes mellitus (DM) that appears in the first 6-9 months of life and necessitates lifelong insulin treatment. We aimed to present the genotypic and phenotypic features of a 13-year-old patient diagnosed with DM at the age of 3 years due to a homozygous variant in the GCK gene.

Methods: The patient's clinical and laboratory findings at follow-up were not consistent with the initial diagnosis of type 1 DM; thus, next-generation sequencing of MODY genes (GCK, HNF1A, HNF1B, and HNF4A genes) was performed to identify monogenic causes of DM.

Results: A novel homozygous variant c.1222 G > T in the GCK gene was revealed. In silico analysis identified it as a pathogenic variant. His mother, father, and brother had the same heterozygous variant in the GCK gene and were diagnosed with MODY 2 (mild fasting hyperglycemia and elevated HbA1c) after genetic counseling.

Conclusion: In this case report, a patient with a homozygous variant in the GCK gene, who was diagnosed with DM after the infantile period, was presented, highlighting the fact that cases with homozygous variants in the GCK gene can, though rarely, present at a later age with a milder phenotype.

Keywords: GCK-MODY; Glucokinase (GCK) gene; Heterozygous mutation; Homozygous mutation; Permanent neonatal diabetes.

PubMed Disclaimer

References

    1. Matschinsky FM (2002) Regulation of pancreatic beta-cell glucokinase: from basics to therapeutics. Diabetes 51(Suppl 3):S394-404 - DOI
    1. Osbak KK, Colclough K, Saint-Martin C, Beer NL, Bellanné-Chantelot C, Ellard S et al (2009) Update on mutations in glucokinase (GCK), which cause maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemic hypoglycemia. Hum Mutat 30(11):1512–1526 - DOI
    1. Glaser B, Kesavan P, Heyman M, Davis E, Cuesta A, Buchs A et al (1998) Familial hyperinsulinism caused by an activating glucokinase mutation. N Engl J Med 338(4):226–230 - DOI
    1. Njølstad PR, Sagen JV, Bjørkhaug L, Odili S, Shehadeh N, Bakry D et al (2003) Permanent neonatal diabetes caused by glucokinase deficiency: inborn error of the glucose-insulin signaling pathway. Diabetes 52(11):2854–2860 - DOI
    1. Esquiaveto-Aun AM, De Mello MP, Paulino MF, Minicucci WJ, Guerra-Júnior G, De Lemos-Marini SH (2015) A new compound heterozygosis for inactivating mutations in the glucokinase gene as cause of permanent neonatal diabetes mellitus (PNDM) in double-first cousins. Diabetol Metab Syndr 7:101 - DOI

LinkOut - more resources